C3 Glomerulopathy (MGRS)

24671835 PDF 2014. C3 glomerulopathy: una rivoluzione nella classificazione delle glomerulonefriti.Template:24671835
28356669 PDF 2017. C3 glomerulopathy associated to multiple myeloma successfully treated by autologous stem cell transplant.Template:28356669
27994856 PDF 2016. C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome.Template:27994856
24357668 PDF 2014. Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.Template:24357668
33774080 PDF 2021. Proliferative Glomerulonephritis With Fibrils, Monoclonal kappa Light Chain, and C3 Deposits.Template:33774080
30474593 PDF 2019. Corticosteroid therapy alone for the treatment of C3 glomerulonephritis in association with monoclonal gammopathy
.Template:30474593
38076230 PDF 2023. C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis.Template:38076230
37724175 PDF 2023. Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review.Template:37724175
37363300 PDF 2023. Immunoelectron microscopy findings in a patient with C3 glomerulonephritis.Template:37363300
37189718 PDF 2023. Diagnostic Problems in C3 Glomerulopathy.Template:37189718
36899849 PDF 2023. Diagnostic and Prognostic Comparison of Immune-Complex-Mediated Membranoproliferative Glomerulonephritis and C3 Glomerulopathy.Template:36899849
36631797 PDF 2023. Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective study.Template:36631797
35777834 PDF 2022. Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis.Template:35777834
35223908 PDF 2022. Case Report: Chronic Lymphocytic Leukemia With Recurrent Complement-Mediated Thrombotic Microangiopathy and C3 Glomerulonephritis.Template:35223908
34703825 PDF 2021. Complete Renal Recovery in Pediatric Patient with C3 Glomerulonephritis: A Case Report.Template:34703825
34616577 PDF 2021. Mycoplasma pneumoniae Infection Associated C3 Glomerulopathy Presenting as Severe Crescentic Glomerulonephritis.Template:34616577
34456924 PDF 2021. Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.Template:34456924
34211499 PDF 2021. CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.Template:34211499
34023209 PDF 2021. Treatment of Monoclonal Gammopathy-associated C3 Glomerulopathy With Daratumumab-based Therapy.Template:34023209
32943008 PDF 2020. C3-glomerulonephritis in New Zealand - a case series.Template:32943008
32816888 PDF 2020. Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease.Template:32816888
32695788 PDF 2020. Diverse Clinical Presentations of C3 Dominant Glomerulonephritis.Template:32695788

31823738 PDF 2019. Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis.'

31384438 PDF 2019. Usefulness of mycophenolate mofetil in Indian patients with C3 glomerulopathy.Template:31384438

30487789 PDF 2018. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.'

30333829 PDF 2018. Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy.'

30186495 PDF 2018. Complement 3 glomerulonephritis in rheumatoid arthritis: A case report and follow-up.Template:30186495
29724174 PDF 2018. Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft.Template:29724174
29594148 PDF 2018. C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction.Template:29594148
29329521 PDF 2018. Treating C3 glomerulopathy with eculizumab.Template:29329521

29166869 PDF 2017. Multimodal imaging of retinal pigment epithelial detachments in patients with C3 glomerulopathy: case report and review of the literature.'

28573137 PDF 2017. Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies.Template:28573137
28357053 PDF 2017. C3 glomerulopathy.Template:28357053
27878657 PDF 2017. C3 glomerulopathy and current dilemmas.Template:27878657
27274824 PDF 2016. Kidney transplant outcomes in familial C3 glomerulopathy.Template:27274824
27200326 PDF 2016. Overview of C3 Glomerulopathy.Template:27200326
26251715 PDF 2015. Timing of eculizumab therapy for C3 glomerulonephritis.Template:26251715
26251714 PDF 2015. Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis.Template:26251714
26069834 PDF 2013. Recovery of renal function succeeding stem cell transplant: a case of C3 Glomerulonephiritis secondary to monoclonal gammopathy.Template:26069834
24178974 PDF 2014. C3 glomerulopathy: clinicopathologic features and predictors of outcome.Template:24178974
22403278 PDF 2012. Eculizumab for dense deposit disease and C3 glomerulonephritis.Template:22403278
21784830 PDF 2011. Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: a fortuitous association?Template:21784830
37176142 PDF 2023. Clinico-Pathogenic Similarities and Differences between Infection-Related Glomerulonephritis and C3 Glomerulopathy.Template:37176142
36938068 PDF 2023. C3 Glomerulopathy and Thrombotic Microangiopathy: A "Hybrid" Phenotype.Template:36938068

36751667 PDF 2022. C3 Glomerulopathy: A Review with Emphasis on Ultrastructural Features.'

34520493 PDF 2021. Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: A retrospective analysis of data from the Japan Renal Biopsy Registry.Template:34520493
33840955 PDF 2020. Clinico-pathological Profile and Outcome of C-3 Glomerulopathy in Indian Children.Template:33840955
33615080 PDF 2021. Efficacy of Eculizumab in Coexisting Complement C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome.Template:33615080
33305125 PDF 2020. Long-Term Outcomes of C3 Glomerulopathy and Immune-Complex Membranoproliferative Glomerulonephritis in Children.Template:33305125
33096866 PDF 2020. Treatment of C3 Glomerulopathy in Adult Kidney Transplant Recipients: A Systematic Review.Template:33096866
32518880 PDF 2020. Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab.Template:32518880
31980588 PDF 2020. CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.Template:31980588
31919107 PDF 2020. Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy.Template:31919107

31703608 PDF 2019. C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy.'

31701048 PDF 2019. Glomerular Complement Factor H-Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment.Template:31701048
30993226 PDF 2019. Transplant Glomerulopathy With Glomerular C3 Deposits: Why the Worse Outcome?Template:30993226

30692664 PDF 2019. C3 glomerulopathy - understanding a rare complement-driven renal disease.'

32734182 PDF 2019. C3 Glomerulonephritis: A Rare Etiology of the Pulmonary Renal Syndrome.Template:32734182
30369521 PDF 2018. Predictive factors for poor outcome in pediatric C3 glomerulonephritis.Template:30369521

30077216 PDF 2018. C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic.'

29729982 PDF 2018. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.'

29030465 PDF 2018. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.Template:29030465
28210641 PDF 2017. Atypical Plasmacytic Proliferation in a Case of C3 Glomerulopathy: Pathophysiology Demystified.Template:28210641
27631242 PDF 2016. C3 glomerulonephritis in multiple myeloma: A case report and literature review.Template:27631242
26471127 PDF 2016. A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H.Template:26471127
26374608 PDF 2016. Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.Template:26374608
25991042 PDF 2015. C4d Staining in the Diagnosis of C3 Glomerulopathy.Template:25991042
25991041 PDF 2015. C4d as a Diagnostic Tool in Proliferative GN.Template:25991041
25684865 PDF 2015. Incidence and profile of C3 Glomerulopathy: A single center study.Template:25684865
25484526 PDF 2014. Current concepts in C3 glomerulopathy.Template:25484526
24172683 PDF 2013. C3 glomerulopathy: consensus report.Template:24172683

23907509 PDF 2013. Soluble CR1 therapy improves complement regulation in C3 glomerulopathy.'

23689905 PDF 2013. Eculizumab and recurrent C3 glomerulonephritis.Template:23689905
23479095 PDF 2013. Recent insights into C3 glomerulopathy.Template:23479095
23204401 PDF 2013. Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis.Template:23204401
22677550 PDF 2012. Pathology after eculizumab in dense deposit disease and C3 GN.Template:22677550

22673887 PDF 2012. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.'

22157657 PDF 2012. Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion.Template:22157657
34658305 PDF 2021. C3 glomerulonephritis associated with monoclonal gammopathy: a retrospective case series study from a single institute in China.Template:34658305
33482806 PDF 2021. C3 glomerulonephritis along with light chain proximal tubulopathy without crystal deposits in multiple myeloma: a case report.Template:33482806
27458560 PDF 2016. Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN.Template:27458560
27500215 PDF 2015. Atypical Hemolytic Uremic Syndrome Recurrence after Renal Transplantation: C3-Glomerulonephritis as an Initial Presentation.Template:27500215
24161036 PDF 2013. Dense deposit disease and C3 glomerulopathy.Template:24161036